{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:08:20Z","timestamp":1761059300414},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.psychres.2012.03.011","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T04:31:54Z","timestamp":1333513914000},"page":"159-163","source":"Crossref","is-referenced-by-count":16,"title":["Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients"],"prefix":"10.1016","volume":"199","author":[{"given":"Robert C.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saumya","family":"Rachakonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2012.03.011_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2165\/00023210-200822070-00002","article-title":"Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders","volume":"22","author":"Alvarez-Jimenez","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2012.03.011_bib2","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/oby.2008.277","article-title":"Adiposity and eating behaviors in patients under second generation antipsychotics","volume":"16","author":"Blouin","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.psychres.2012.03.011_bib3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1345\/aph.1G564","article-title":"Naturalistic impact of second-generation antipsychotics on weight gain","volume":"40","author":"Brixner","year":"2006","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/j.psychres.2012.03.011_bib4","first-page":"10","article-title":"The potential role of appetite in predicting weight changes during treatment with olanzapine","author":"Case","year":"2010","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2012.03.011_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0924-977X(02)00127-X","article-title":"Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial","volume":"13","author":"Cavazzoni","year":"2003","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2012.03.011_bib6","first-page":"e55","article-title":"Chronic administration of olanzapine affects behavioral satiety sequence and feeding behavior in female mice","volume":"13","author":"Coccurello","year":"2008","journal-title":"Eating and Weight Disorders"},{"key":"10.1016\/j.psychres.2012.03.011_bib7","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","article-title":"A preprandial rise in plasma ghrelin levels suggest a role in meal initiation in humans","volume":"50","author":"Cummings","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.psychres.2012.03.011_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.euroneuro.2004.03.005","article-title":"Amantadine for weight gain associated with olanzapine treatment","volume":"15","author":"Deberdt","year":"2005","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2012.03.011_bib9","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1038\/sj.npp.1301051","article-title":"Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents","volume":"31","author":"Elman","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2012.03.011_bib10","doi-asserted-by":"crossref","unstructured":"Evers, S., Calcagnoli, F., Van Dijk, C., Scheurink, A., 2010. Olanzapine causes hypothermia, inactivity, a deranged feeding pattern and weight gain in female Wistar rats. Pharmacology Biochemistry and Behavior 97 (1), 163\u2013169","DOI":"10.1016\/j.pbb.2010.05.029"},{"key":"10.1016\/j.psychres.2012.03.011_bib11","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1176\/appi.ajp.159.6.1055","article-title":"Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine","volume":"159","author":"Gothelf","year":"2002","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2012.03.011_bib12","first-page":"33","article-title":"Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone","volume":"22","author":"Henderson","year":"2010","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2012.03.011_bib13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1124\/mi.2.8.494","article-title":"Ghrelin and the regulation of food intake and energy balance","volume":"2","author":"Hosoda","year":"2002","journal-title":"Molecular Interventions"},{"key":"10.1016\/j.psychres.2012.03.011_bib14","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1073\/pnas.0611417104","article-title":"Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-lined activation of hypothalamic AMP-kinase","volume":"104","author":"Kim","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.psychres.2012.03.011_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment\u2014pharmacological mechanisms","volume":"125","author":"Reynolds","year":"2010","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.psychres.2012.03.011_bib16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.jcp.0000177549.36585.29","article-title":"A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors","volume":"25","author":"Roerig","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2012.03.011_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.33549\/physiolres.930220","article-title":"Ghrelin\u2014a new endogenous growth hormone secretagogue","volume":"51","author":"Rosicka","year":"2002","journal-title":"Physiological Research"},{"key":"10.1016\/j.psychres.2012.03.011_bib18","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/schbul\/sbm141","article-title":"Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review","volume":"34","author":"Sentissi","year":"2008","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.psychres.2012.03.011_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/YIC.0b013e32832b6bf6","article-title":"Impact of antipsychotic treatments on the motivation to eat: preliminary results in 153 schizophrenic patients","volume":"24","author":"Sentissi","year":"2009","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.psychres.2012.03.011_bib20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.schres.2010.04.001","article-title":"Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study","volume":"120","author":"Smith","year":"2010","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2012.03.011_bib21","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4088\/JCP.08m04446yel","article-title":"Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study","volume":"70","author":"Smith","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2012.03.011_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-9-12","article-title":"Predictors and correlates for weight changes in patients treated with olanzapine and weight mitigating agents: a post-hoc analysis","volume":"9","author":"Stauffer","year":"2009","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2012.03.011_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/oxfordjournals.schbul.a007013","article-title":"Nutritional assessment of patients with schizophrenia: a preliminary study","volume":"29","author":"Strassnig","year":"2003","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.psychres.2012.03.011_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.schres.2005.03.002","article-title":"Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia","volume":"76","author":"Strassnig","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2012.03.011_bib25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/15622970903079507","article-title":"Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: results from a six-month prospective, multinational, observational study","volume":"10","author":"Treuer","year":"2009","journal-title":"The World Journal of Biological Psychiatry"},{"key":"10.1016\/j.psychres.2012.03.011_bib26","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1210\/jc.86.12.5992","article-title":"Ghrelin enhances appetite and increases food intake in humans","volume":"86","author":"Wren","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178112001205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178112001205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T19:08:32Z","timestamp":1713812912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178112001205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0165178112001205"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2012.03.011","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}